Facible BioDiagnostics, Inc.
OperatingHealthcare · Meridian, ID
Financials
FY2021 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Cap table
Share counts as of Oct 7, 2022| Class | Outstanding | Votes / share | Share of total | Votes | Last price |
|---|---|---|---|---|---|
| Preferred Stockpreferred | 18,840,621 | — | 28.1% | 8.68% | — |
| Class A Common Stock | 29,346,045 | 1 | 43.8% | 13.5% | — |
| Class B Common Stock | 18,775,000 | 9 | 28.0% | 77.8% | — |
| Total | 66,961,666 | 100% | 100% |
Principal holders% as the filing states it, Oct 7, 2022
- Steven Burden16,025,000 Class B85.3%of Class B
- Steven Burden16,025,000 Class A73.6%of Class A
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
4 peopleNames and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.
SEC filings
View all 12 filings on EDGAR- Form 1-SAMar 31, 20230001910594-23-000001EDGAR
- Form 1-A POSOct 7, 20220001910594-22-000019EDGAR
- Form QUALIFOct 7, 20229999999994-22-000389EDGAR
- Form 1-SASep 27, 20220001910594-22-000017EDGAR
- Form 1-A POSSep 20, 20220001910594-22-000015EDGAR
- Form QUALIFAug 19, 20229999999994-22-000309EDGAR
- Form 1-A POSAug 9, 20220001910594-22-000012EDGAR
- Form QUALIFJul 28, 20229999999994-22-000282EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.